Skip to main content
HR 1732 115th Congress House Crime and Law Enforcement Drug trafficking and controlled substances

Synthetic Drug Control Act of 2017

Introduced: March 27, 2017 See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 12, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Mar 31, 2017
Referred to the Subcommittee on Health.
Mar 27, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 27, 2017
Introduced in House
 Plain-English summary Congressional Research Service

Synthetic Drug Control Act of 2017

This bill directs the Drug Enforcement Administration to update schedule I of the Controlled Substances Act to include certain synthetic substances. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

The bill exempts from treatment as a controlled substance any such synthetic substance that is manufactured, distributed, and used exclusively for research.

What's happening now April 12, 2017

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

 Committees of jurisdiction 4